Literature DB >> 15261857

Patterns of abnormal motor cortex excitability in atypical parkinsonian syndromes.

A A Kühn1, P Grosse, K Holtz, P Brown, B-U Meyer, A Kupsch.   

Abstract

OBJECTIVE: Multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal-ganglionic degeneration (CBGD) are all clinically characterized by an akinetic-rigid syndrome together with a variety of additional signs. We hypothesised that these atypical parkinsonian syndromes (APS) will show distinctive patterns in their motor output upon transcranial magnetic stimulation (TMS) due to their different underlying anatomico-functional deficits.
METHODS: We performed single and paired-pulse TMS and assessed inhibitory and excitatory response parameters from the first dorsal interosseus muscles in 13 patients with MSA, 18 with PSP, 13 with CBGD, 15 patients with Parkinson's disease and 17 healthy subjects.
RESULTS: PSP and MSA patients had significantly enlarged response amplitudes at rest, reduced intracortical inhibition (ICI) and prolonged ipsi- and contralateral silent periods, whereas CBGD patients showed significantly increased motor thresholds, smaller response amplitudes at rest, shortened contralateral silent period, reduced transcallosal inhibition and a reduced ICI. In 22% of APS patients ipsilateral motor responses occurred in upper limb muscles irrespective of the underlying disease.
CONCLUSIONS: Our results indicate that motor cortex disinhibition is predominant in patients with PSP and MSA. In CBGD more severe neuronal cell loss in the motor cortex itself may lead to hypoexcitability of corticospinal and transcallosal pathways.

Entities:  

Mesh:

Year:  2004        PMID: 15261857     DOI: 10.1016/j.clinph.2004.03.020

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  21 in total

Review 1.  Neurophysiology and neurochemistry of corticobasal syndrome.

Authors:  Aditya A Murgai; Mandar S Jog
Journal:  J Neurol       Date:  2018-01-06       Impact factor: 4.849

2.  Current and future treatments in progressive supranuclear palsy.

Authors:  Irene van Balken; Irene Litvan
Journal:  Curr Treat Options Neurol       Date:  2006-05       Impact factor: 3.598

3.  Interhemispheric inhibition in different phenotypes of progressive supranuclear palsy.

Authors:  M Wittstock; I Pohley; U Walter; A Grossmann; R Benecke; A Wolters
Journal:  J Neural Transm (Vienna)       Date:  2012-08-15       Impact factor: 3.575

Review 4.  Physiological changes in neurodegeneration - mechanistic insights and clinical utility.

Authors:  Rebekah M Ahmed; Yazi D Ke; Steve Vucic; Lars M Ittner; William Seeley; John R Hodges; Olivier Piguet; Glenda Halliday; Matthew C Kiernan
Journal:  Nat Rev Neurol       Date:  2018-03-23       Impact factor: 42.937

Review 5.  Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease.

Authors:  Steve Vucic; Matthew C Kiernan
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

6.  Corticobasal degeneration: clinical characteristics and multidisciplinary therapeutic approach in 26 patients.

Authors:  Hatem S Shehata; Nevin M Shalaby; Eman H Esmail; Ebtesam Fahmy
Journal:  Neurol Sci       Date:  2015-04-28       Impact factor: 3.307

7.  Effects of dopamine depletion on network entropy in the external globus pallidus.

Authors:  Ana V Cruz; Nicolas Mallet; Peter J Magill; Peter Brown; Bruno B Averbeck
Journal:  J Neurophysiol       Date:  2009-06-17       Impact factor: 2.714

8.  Transcranial magnetic stimulation and brain atrophy: a computer-based human brain model study.

Authors:  Tim Wagner; Uri Eden; Felipe Fregni; Antoni Valero-Cabre; Ciro Ramos-Estebanez; Valerie Pronio-Stelluto; Alan Grodzinsky; Markus Zahn; Alvaro Pascual-Leone
Journal:  Exp Brain Res       Date:  2008-01-10       Impact factor: 1.972

Review 9.  Evolving concepts on bradykinesia.

Authors:  Matteo Bologna; Giulia Paparella; Alfonso Fasano; Mark Hallett; Alfredo Berardelli
Journal:  Brain       Date:  2020-03-01       Impact factor: 13.501

10.  Altered callosal function in cerebral microangiopathy.

Authors:  Matthias Wittstock; Annette Grossmann; Erwin Kunesch; Uwe Walter; Reiner Benecke; Alexander Wolters
Journal:  J Neurol       Date:  2009-11-16       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.